After the administration of Columvi, cytokine release syndrome occurred in 70% of patients, including a lower incidence for ...

I am proposing that all companies currently engaged in developing biosimilars join hands with their regulatory and scientific ...

Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in ...

Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...

Idiopathic Membranous Nephropathy Treatment Market is projected to witness substantial growth over the next few years, driven ...

While Roche wasn’t able to show efficacy for its Rituxan brand of rituximab in trials, follow-up Gazyva (obinutuzumab) did better than placebo when added to standard care in the NOBILITY trial.

Roche and AbbVie’s Venclexta (venetoclax) has been approved by the FDA in combination with Roche’s Gazyva (obinutuzumab) for the treatment of people with previously untreated chronic ...

At the 42nd Annual Chemotherapy Foundation Symposium, Erin Mulvey, MD, discussed the significant progress being made in the ...

Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society of ...

Trump Suggests Use of Emergency Powers and the Military for Deportations Donald Trump addressed his plans for mass deportations in a social media post. He is expected to interview candidates for ...

UNRWA, the main U.N. agency aiding Palestinians, said its drivers were forced to unload supplies at gunpoint, in what it called one of the worst such incidents of the war. By Hiba Yazbek The ...

Will the Senate serve as a check on Trump’s power or pave the way for his agenda? The Senate returns to Washington facing more tough decisions about controversial nominations by Donald Trump.